Raymond James & Associates’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $342K | Buy |
|
|||||
|
2024
Q2 | $326K | Sell |
|
|||||
|
2024
Q1 | $426K | Sell |
|
|||||
|
2023
Q4 | $558K | Sell |
|
|||||
|
2023
Q3 | $691K | Buy |
|
|||||
|
2023
Q2 | $815K | Buy |
|
|||||
|
2023
Q1 | $545K | Sell |
|
|||||
|
2022
Q4 | $1.02M | Buy |
|
|||||
|
2022
Q3 | $221K | Sell |
|
|||||
|
2022
Q2 | $448K | Buy |
|
|||||
|
2022
Q1 | $546K | Sell |
|
|||||
|
2021
Q4 | $834K | Buy |
|
|||||
|
2021
Q3 | $958K | Buy |
|
|||||
|
2021
Q2 | $888K | Buy |
|
|||||
|
2021
Q1 | $712K | Buy |
|
|||||
|
2020
Q4 | $441K | Sell |
|
|||||
|
2020
Q3 | $412K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $100K | Buy |
|